Literature DB >> 27169533

Current data on acute haematogenous osteomyelitis in children in Southern Israel: epidemiology, microbiology, clinics and therapeutic consequences.

Eugen Cohen1, Karin Lifshitz1, Yariv Fruchtman2, Mark Eidelman3, Eugene Leibovitz4.   

Abstract

BACKGROUND: Acute haematogenous osteomyelities (AHO) is the most common form of osteomyelitis, occurring when bone is infected secondary to transient bacteremia. The prevalence, aetiology and outcome of AHO may vary from region to region and period to period. The study objectives were to define the epidemiology, clinical, laboratory and imaging characteristics and treatment consequences of AHO in children in southern Israel.
METHODS: This was a retrospective cohort study, enrolling all children <16 years of age hospitalized with AHO. Epidemiologic, clinical, laboratory and imaging data were recorded from medical charts.
RESULTS: Ninety-one patients were diagnosed with AHO (52.7 % <4 years of age). Most children (80.24 %) did not receive antibiotic treatment prior to diagnosis. During 2005-2012 the AHO incidence was 5.6:100,000; the AHO incidence in the Bedouin and Jewish population was 7.3 and 4.1:100,000, respectively. Fifty-four (57.8 %) patients were afebrile at admission and 34 (37.4 %) showed leukocytosis >15,000/mm(3). The most involved bone was tibia (39.6 %), followed by femur (19.8 %), humerus (8.8 %) and pelvis (8.8 %). Positive cultures were reported in 26 (28.6 %) patients. The most common pathogen was methicillin-susceptible Staphylococcus aureus (MSSA, 18 patients, 19.8 %). There was only one case of MRSA. More positive cultures were recorded among children requiring surgery compared to children treated conservatively (P < 0.01). MSSA representation in cases requiring surgical intervention was higher than in cases treated conservatively (P = 0.01). There were nine bone biopsies and 33 bone aspirations (MSSA in 44.4 % and 24.2 %, respectively). The longest hospitalization was observed in patients with humerus-AHO (14.8 ± 12.2 days). There was no difference in the number of days of hospitalization between patients who received previous antibiotics compared with children who did not receive antibiotics before admission.
CONCLUSIONS: Tibia was the most frequently involved bone, but humeral AHO required more surgical intervention and longer hospitalization. Negative cultures were frequent, MSSA was the most commonly involved pathogen and MRSA was rare. Culture positive AHO was associated with higher requirement for surgical intervention.

Entities:  

Keywords:  Acute haematogenous osteomyelitis; Antibiotics; Children; Kingella kingae; Staphylococcus aureus; Surgery

Mesh:

Substances:

Year:  2016        PMID: 27169533     DOI: 10.1007/s00264-016-3211-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  28 in total

1.  A proposed scoring system for assessment of severity of illness in pediatric acute hematogenous osteomyelitis using objective clinical and laboratory findings.

Authors:  Lawson A B Copley; Theresa Barton; Carla Garcia; David Sun; Claudia Gaviria-Agudelo; William T Gheen; Richard H Browne
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

2.  A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice.

Authors:  D Fraser; N Givon-Lavi; N Bilenko; R Dagan
Journal:  Clin Infect Dis       Date:  2001-07-11       Impact factor: 9.079

3.  Pediatric Acute Hematogenous Osteomyelitis.

Authors:  Matthew Street; Rupesh Puna; Mark Huang; Haemish Crawford
Journal:  J Pediatr Orthop       Date:  2015-09       Impact factor: 2.324

4.  Prospective survey of acute osteoarticular infections in a French paediatric orthopedic surgery unit.

Authors:  A Ferroni; H Al Khoury; C Dana; G Quesne; P Berche; C Glorion; Z Péjin
Journal:  Clin Microbiol Infect       Date:  2013-09       Impact factor: 8.067

5.  Osteomyelitis in Polynesian children.

Authors:  Melissa Rossaak; Rocco P Pitto
Journal:  Int Orthop       Date:  2004-10-14       Impact factor: 3.075

6.  Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel.

Authors:  J Bonhoeffer; B Haeberle; U B Schaad; U Heininger
Journal:  Swiss Med Wkly       Date:  2001-10-06       Impact factor: 2.193

7.  Comparison of the characteristics of culture-negative versus culture-positive septic arthritis in children.

Authors:  Wei-Szu Chang; Nan-Chang Chiu; Hsin Chi; Wen-Chen Li; Fu-Yuan Huang
Journal:  J Microbiol Immunol Infect       Date:  2005-06       Impact factor: 4.399

8.  Significance of Negative Cultures in the Treatment of Acute Hematogenous Bone and Joint Infections in Children.

Authors:  Markus Pääkkönen; Markku J T Kallio; Pentti E Kallio; Heikki Peltola
Journal:  J Pediatric Infect Dis Soc       Date:  2013-01-10       Impact factor: 3.164

Review 9.  Patterns of Kingella kingae Disease Outbreaks.

Authors:  Nawal El Houmami; Philippe Minodier; Grégory Dubourg; Audrey Mirand; Jean-Luc Jouve; Romain Basmaci; Rémi Charrel; Stéphane Bonacorsi; Pablo Yagupsky; Didier Raoult; Pierre-Edouard Fournier
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

10.  Differences in the epidemiology of childhood community-acquired bacterial meningitis between two ethnic populations cohabiting in one geographic area.

Authors:  J Rosenthal; R Dagan; J Press; S Sofer
Journal:  Pediatr Infect Dis J       Date:  1988-09       Impact factor: 2.129

View more
  9 in total

1.  Pediatric Orthopaedics - from Kirschner wires to titanium.

Authors:  Patricia M M B Fucs; Marius M Scarlat
Journal:  Int Orthop       Date:  2017-12       Impact factor: 3.075

2.  [Acute haematogenous osteomyelitis in children : Diagnostic algorithm and treatment strategies].

Authors:  M Willegger; A Kolb; R Windhager; C Chiari
Journal:  Orthopade       Date:  2017-06       Impact factor: 1.087

3.  The role of real-time PCR testing in the investigation of paediatric patients with community-onset osteomyelitis and septic arthritis.

Authors:  Sadhbh O'Rourke; Mary Meehan; Désirée Bennett; Nicola O'Sullivan; Robert Cunney; Patrick Gavin; Roisin McNamara; Noelle Cassidy; Stephanie Ryan; Kathryn Harris; Richard Drew
Journal:  Ir J Med Sci       Date:  2019-01-31       Impact factor: 1.568

4.  Pediatric Septic Arthritis and Osteomyelitis in the USA: A National KID Database Analysis.

Authors:  Gabriella Safdieh; Jason Silberman; Joseph Nguyen; Shevaun M Doyle; John S Blanco; David M Scher; Daniel W Green; Roger F Widmann; Emily R Dodwell
Journal:  HSS J       Date:  2018-11-12

5.  Current data on extremities chronic osteomyelitis in southwest China: epidemiology, microbiology and therapeutic consequences.

Authors:  Xiaohua Wang; Shengpeng Yu; Dong Sun; Jingshu Fu; Shulin Wang; Ke Huang; Zhao Xie
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

6.  Epidemiology and Management of Acute Haematogenous Osteomyelitis in a Tertiary Paediatric Center.

Authors:  Elena Chiappini; Caterina Camposampiero; Simone Lazzeri; Giuseppe Indolfi; Maurizio De Martino; Luisa Galli
Journal:  Int J Environ Res Public Health       Date:  2017-05-04       Impact factor: 3.390

7.  Antimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) Microspheres.

Authors:  Zhi Zhou; Qingqiang Yao; Lan Li; Xin Zhang; Bo Wei; Li Yuan; Liming Wang
Journal:  Med Sci Monit       Date:  2018-09-30

8.  Nationwide epidemiologic study for pediatric osteomyelitis and septic arthritis in South Korea: A cross-sectional study of national health insurance review and assessment service.

Authors:  Jihye Kim; Min Uk Lee; Tae-Hwan Kim
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  A Comparison of the Epidemiology, Clinical Features, and Treatment of Acute Osteomyelitis in Hospitalized Children in Latvia and Norway.

Authors:  Elise Evja Thingsaker; Urzula Nora Urbane; Jana Pavare
Journal:  Medicina (Kaunas)       Date:  2021-01-04       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.